Navigation Links
Call for Submissions: ICAP Patent Brokerage Announces Expansion of Life Sciences Practice and Increased Buyer Interest in Related Intellectual Property
Date:10/25/2012

LOS ANGELES, Oct. 25, 2012 /PRNewswire/ -- ICAP Patent Brokerage announces expansion of its Life Sciences practice and calls for intellectual property submissions to answer buyer demand. Key new hires have been added to the Los Angeles office to handle growing interest in IP portfolios from this and related technology sectors, including Biotechnology and Pharmaceuticals. Potential buyers are interested in reviewing portfolios immediately, providing patent owners a unique opportunity to monetize assets quickly and efficiently.

(Logo: http://photos.prnewswire.com/prnh/20100614/CG20517LOGO

"With a proven track record selling IP across the globe, we are excited to expand our presence in the Life Sciences and associated fields in response to unprecedented buyer demand. The cutting-edge inventions developed in these areas have endless possibilities – improve medical care, find cures, and enhance quality of life – when matched with the right buyer," says Dean Becker, CEO of ICAP Patent Brokerage.

Call for Intellectual Property Submissions   
Interested buyers are standing by to review portfolios in the following technology sectors:

  • Biotechnology
  • Diagnostics
  • Disease Prevention
  • Health and Aging
  • Life Sciences
  • Medical Devices
  • Pharmaceuticals
  • Therapeutics
  • And More...

For more information on this service offering development, contact Dean Becker of ICAP Patent Brokerage at Dean.Becker@us.icap.com. Visit ICAP Patent Brokerage to learn about service platforms available to buyers and sellers – patent auction and private IP brokerage – as well as to see the IP portfolios currently available for sale.

Upcoming Events   
Join us for the Fall 2012 Patent Monetization Event and IP Auction on November 28 and 29 at The Ritz Carlton in San Francisco, California. Register for the event or submit IP for consideration for the patent auction.

Follow us on Twitter (@ICAP_Auction_IP) and join our LinkedIn group.

About ICAP Patent Brokerage   
ICAP Patent Brokerage is a division of ICAP plc and the world's largest intellectual property brokerage and patent auction firm.

About ICAP   
ICAP is the world's leading interdealer broker and provider of post trade risk and information services. The Group matches buyers and sellers in the wholesale markets in interest rates, credit, commodities, FX, emerging markets and equity derivatives through voice and electronic networks. Through our post trade risk and information services we help our customers manage and mitigate risks in their portfolios. For more information, go to www.icap.com.


'/>"/>
SOURCE ICAP Patent Brokerage
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Harvest Technologies Corporation Files Patent Infringement Complaint against ThermoGenesis Corporation
2. Generics Analysis: Key Patent Case Reviews
3. VirtualScopics Receives Issuance of Influential Patent in Canada
4. Sequent Medical, Inc. Awarded U.S. Patent for MicroBraid Technology
5. Avaxia Biologics is Awarded U.S. Patent for Antibody Therapy for Modulating Function of Intestinal Receptors and Methods of Treating Diabetes and Obesity
6. Lifeline Biotechnologies Receives Third Software Patent
7. Soligenix Announces Issuance of US Patent for Topically Active Steroids to Treat Inflammatory Gastrointestinal Disorders
8. Solta Medical And BTL Industries Resolve Patent Dispute
9. Eaton Scientific Systems, Ltd. completes its Study Protocol for its Planned Clinical Trial of its Patent Pending Non-Hormonal Treatment of Hot Flashes.
10. Hologic Announces Verdict In Patent Infringement Suit
11. OncoSec Granted New Patent from China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2017)... Md. , July 11, 2017  The global ... estimated revenues of approximately $394.1 million in 2016.  Although ... trend of solid growth, in particular as a result ... clinical practice, and the recent introduction of a significant ... need for less-invasive testing of tumor biomarkers to guide ...
(Date:7/11/2017)... 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... company focused on the development of oral drug delivery ... Administration (FDA) has agreed to schedule an End-of-Phase II ... trial of its oral insulin capsule ORMD-0801 in the ... met primary and secondary endpoints by indicating a statistically ...
(Date:7/10/2017)... , July 10, 2017  BDI Group ... and patient support services organization serving specialty pharmacies, ... the launch of four significant, value-added member programs ... insights, better manage reimbursement and improve access and ... factor therapies. ...
Breaking Medicine Technology:
(Date:7/25/2017)... ... July 25, 2017 , ... ... announced it will be exhibiting and providing demos of its smart journaling platform ... Washington Convention Center in Washington D.C. from August 3-6, 2017. , The APA ...
(Date:7/25/2017)... Jacksonville, Fla. (PRWEB) , ... July 25, 2017 , ... ... employee and father Ezra Clark is taking advantage of a new benefit for employees ... “It really means a lot that the company supports me and other employees as ...
(Date:7/24/2017)... Florida (PRWEB) , ... July ... ... Division Marketing Director,      (407) 916-7235, kklaproth(at)robinsmorton(dot)com , Robins & ... joined together to celebrate the structural topping out of the new Destination ...
(Date:7/24/2017)... , ... July 24, 2017 , ... ... federal Substance Abuse and Mental Health Services Administration’s (SAMHSA) State Targeted Response to ... Department of Health Care Services, will facilitate the development of a hub and ...
(Date:7/24/2017)... ... ... The International Essential Tremor Foundation (IETF) will host a free educational forum in ... take place on Saturday, Aug. 26 at the Embassy Suites by Hilton Cleveland Rockside ... a.m. to 12 p.m., with check-in beginning at 8 a.m. The event is sponsored ...
Breaking Medicine News(10 mins):